These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 6348975

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunization of mice with a mutant of Cryptococcus neoformans. Characterization of the mutant, actively acquired resistance to experimental cryptococcosis in mice.
    Reiss F, Alture-Werber E.
    Dermatologica; 1976; 152(1):16-22. PubMed ID: 780165
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans.
    Mody CH, Chen GH, Jackson C, Curtis JL, Toews GB.
    J Lab Clin Med; 1993 Jun; 121(6):765-73. PubMed ID: 7685044
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.
    Murphy JW, Moorhead JW.
    J Immunol; 1982 Jan; 128(1):276-83. PubMed ID: 6172483
    [Abstract] [Full Text] [Related]

  • 10. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice.
    Hoag KA, Street NE, Huffnagle GB, Lipscomb MF.
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):487-95. PubMed ID: 7546779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans].
    Rodríguez Sánchez H, Pupo Antúnez M, Ilnait MT, Otero A, Martínez Machín G.
    Rev Cubana Med Trop; 2005 Oct; 57(2):162-4. PubMed ID: 17966590
    [Abstract] [Full Text] [Related]

  • 18. Influence of cryptococcal antigens on cell-mediated immunity.
    Murphy JW.
    Rev Infect Dis; 1988 Oct; 10 Suppl 2():S432-5. PubMed ID: 2973118
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan.
    Maitta RW, Datta K, Pirofski LA.
    Vaccine; 2004 Sep 28; 22(29-30):4062-8. PubMed ID: 15364457
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.